51662-1557 : Neostigmine Methylsulfate 1 mg/ml Intravenous Injection


NDC: 51662-1557
Labeler: Hf Acquisition Co LLC, Dba Healthfirst
Product Type: Human Prescription Drug
Drug Name: Neostigmine Methylsulfate
Dosage Form: Intravenous Injection
Application #: ANDA209933
Rev. Date: 


NDC Package Codes:

  • 51662-1557-3: 10 POUCH IN 1 CASE (51662‑1557‑3) > 1 CARTON IN 1 POUCH (51662‑1557‑2) > 1 VIAL, MULTI‑DOSE IN 1 CARTON > 10 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Neostigmine Methylsulfate

Dosage Strength:

  • 1 mg/mL

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0404-9925 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Henry Schein, Inc.
  • 0517-0033 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-0034 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection, Solution by American Regent, Inc.
  • 0517-1133 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by American Regent, Inc.
  • 0517-1134 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by American Regent, Inc.
  • 0548-9601 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Amphastar Pharmaceuticals, Inc.
  • 0548-9602 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Amphastar Pharmaceuticals, Inc.
  • 0641-6076 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6077 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6140 Neostigmine Methylsulfate 1 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6141 Neostigmine Methylsulfate .5 mg/ml Intramuscular; Intravenous; Subcutaneous Injection by West-ward Pharmaceutical Corp.
  • 0641-6149 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6150 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by West-ward Pharmaceuticals Corp.
  • 0641-6240 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0641-6264 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 0641-6265 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Hikma Pharmaceuticals USA Inc.
  • 14445-413 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Indoco Remedies Limited
  • 14445-414 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Indoco Remedies Limited
  • 23155-517 Neostigmine Methylsulfate .5 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
  • 23155-518 Neostigmine Methylsulfate 1 mg/ml Intravenous Injection by Heritage Pharmaceuticals Inc. D/B/A Avet Pharmaceuticals Inc.
  • More related products ...

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 51662-1557 QR Code

< Prev: 51662-1556Next: 51662-1558 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.